Wednesday, August 13, 2014

WHO Confirms: It Is Ethical to Use "Unapproved Interventions" in Ebola Outbreak

Memorandum

Date: August 12, 2014
.
From:
 Ralph Fucetola JD. Natural Solutions Foundation Counsel
.
To: Rima E. Laibow MD, Natural Solutions Foundation Medical Director”
.
Re: Legal Status of the Foundation’s Ebola Nano Silver Initiative

.
Legal Question Presented: What is the current legal status of recommending Nano Silver as an intervention during the current Ebola Outbreak?
.
Legal Principles: International and national law set out regulations regarding the standard practice of medicine. In most countries, physicians are restricted by their licenses to the practice of standard medicine. Physicians can rely on the standards of practice in ordinary circumstances. Similarly, regulations have been developed regarding medical experimentation on individuals. However, during a humanitarian emergency, other concerns become more pressing.
.
The World Health Organization (WHO), which has declared an international health emergency today, repeated these international principles in a declaration regarding Ebola and “unapproved interventions…”*
In the particular circumstances of this outbreak, and provided certain conditions are met, the panel reached consensus that it is ethical to offer unproven interventions with as yet unknown efficacy and adverse effects, as potential treatment or prevention. [Emphasis added.]
Ethical criteria must guide the provision of such interventions. These include transparency about all aspects of care, informed consent, freedom of choice, confidentiality, respect for the person, preservation of dignity and involvement of the community.
Analysis: Nano Silver provides a therapy that may benefit and should be readily available without restriction.
.
Natural Solutions Foundation supports the international standards enunciated by the World Medical Association in its Helsinki Declaration.** The basic principles involve informed consent and doing no intentional harm. US Federal law has similar restrictions on human experimentation.
.
The WMA declaration states:
It is the duty of physicians who are involved in medical research to protect the life, health, dignity, integrity, right to self-determination, privacy, and confidentiality of personal information of research subjects.
These restrictions must be considered in light of the current Ebola Outbreak and with regard to the 2009 declassification of the  US Air Force sponsored in vitro Ebola / Nano Silver study that proved the effectiveness of Nano Silver as a virus replication inactivator: http://drrimatruthreports.com/smoking-gun-us-suppressing-ebola-therapy-since-2009/
.
I have reviewed the Dr. Rima Nano Silver Ebola Clinical Test Protocol. This document, provided to the Ebola “front line” states, shows that the test proposal meets these international standards. Several West African states have indicated in writing their willingness to allow Clinical Tests with patients suffering from Ebola, pursuant to the Protocol. A copy of the Protocol may be obtained here: http://tinyurl.com/ebolaprotocol
.
The purpose of this Memorandum is to assure the cooperating physicians and the public health authorities of West Africa that, in addition to the United States FDA approval of Nano Silver as a surface disinfectant, the provision of food-grade Nano Silver for ingestion by the patients should be considered a humanitarian exception to any current restrictions, as allowed by the WHO pronouncement.
.
The Protocol requires informed patient consent and consideration. The safety of Nano Silver, which is self-sterilizing and can be stored a ambient temperature, under the circumstances of an outbreak of hemorrhagic infection, is not in serious question.
.
Thus the primary concerns expressed by WHO are met.
.
It is therefore my professional opinion that the Foundation’s Nano Silver Ebola Initiative conforms to this non-governmental organization (NGO)’s Mission, as its expressive association, and that is is ethical for physicians to cooperate with the Clinical Test as provided in the Protocol.
.
Ralph Fucetola JD
.

No comments: